Valproate modulates glucose metabolism in patients with epilepsy after first exposure
- PMID: 26250143
- DOI: 10.1111/epi.13114
Valproate modulates glucose metabolism in patients with epilepsy after first exposure
Abstract
Valproate (VPA) treatment has been reported to be associated with weight gain and metabolic changes, such as hyperinsulinemia. The question of whether hyperinsulinemia and other metabolic changes are consequences of increased weight, or are instead direct results of VPA treatment, remains a matter of debate. The aim of the current study was to explore the influence of VPA treatment on glucose and insulin levels during the oral glucose tolerance test (OGTT) directly following the first intravenous (IV) administration. Sixteen patients (18-46 years old) with newly diagnosed epilepsy underwent an OGTT with 75 g glucose prior to the start of VPA treatment, as well as directly following the first IV VPA administration. We observed that plasma glucose levels during the 120 min of OGTT session following infusion of VPA were significantly lower than those measured during OGTT without VPA treatment (mean ± standard deviation [SD] 4.28 ± 0.94 mmol/l vs. 4.75 ± 1.09 mmol/l respectively, p = 0.038). However, blood concentrations of insulin and C-peptide did not differ significantly between the two measurements. This is the first study to show a potential acute glucose-lowering effect of VPA during OGTT in patients with newly diagnosed epilepsy.
Keywords: Glucose; Insulin; Insulin resistance; Valproate; Valproic acid.
Wiley Periodicals, Inc. © 2015 International League Against Epilepsy.
Similar articles
-
Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.Metabolism. 2002 Oct;51(10):1274-8. doi: 10.1053/meta.2002.34708. Metabolism. 2002. PMID: 12370846 Clinical Trial.
-
Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.Epilepsy Behav. 2006 May;8(3):643-8. doi: 10.1016/j.yebeh.2006.02.008. Epub 2006 Apr 5. Epilepsy Behav. 2006. PMID: 16600693
-
Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.Epilepsia. 2005 Jun;46(6):949-51. doi: 10.1111/j.1528-1167.2005.69703.x. Epilepsia. 2005. PMID: 15946337 Clinical Trial.
-
Valproate-induced insulin resistance and obesity in children.Horm Res. 2009;71(3):125-31. doi: 10.1159/000197868. Epub 2009 Feb 3. Horm Res. 2009. PMID: 19188736 Review.
-
Metabolic and endocrine effects of valproic acid chronic treatment.Epilepsy Res. 2013 Nov;107(1-2):1-8. doi: 10.1016/j.eplepsyres.2013.08.016. Epub 2013 Sep 4. Epilepsy Res. 2013. PMID: 24076030 Review.
Cited by
-
Preclinical Study in Mouse Thymus and Thymocytes: Effects of Treatment with a Combination of Sodium Dichloroacetate and Sodium Valproate on Infectious Inflammation Pathways.Pharmaceutics. 2023 Nov 30;15(12):2715. doi: 10.3390/pharmaceutics15122715. Pharmaceutics. 2023. PMID: 38140056 Free PMC article.
-
RNA-seq analysis of blood of valproic acid-responsive and non-responsive pediatric patients with epilepsy.Exp Ther Med. 2019 Jul;18(1):373-383. doi: 10.3892/etm.2019.7538. Epub 2019 Apr 30. Exp Ther Med. 2019. PMID: 31258675 Free PMC article.
-
Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?Front Endocrinol (Lausanne). 2017 Jun 26;8:147. doi: 10.3389/fendo.2017.00147. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28694790 Free PMC article. No abstract available.
-
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences.Pharmaceutics. 2024 Mar 16;16(3):409. doi: 10.3390/pharmaceutics16030409. Pharmaceutics. 2024. PMID: 38543303 Free PMC article.
-
Ameliorative Potential of (-) Pseudosemiglabrin in Mice with Pilocarpine-Induced Epilepsy: Antioxidant, Anti-Inflammatory, Anti-Apoptotic, and Neurotransmission Modulation.Int J Mol Sci. 2023 Jun 28;24(13):10773. doi: 10.3390/ijms241310773. Int J Mol Sci. 2023. PMID: 37445950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical